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depots may underlie this risk differential. However, prospective studies of directly measured fat are limited.Methods Participants from the Framingham Heart Study (n ¼ 3,086; 49% women; mean age of 50.2 years) underwent
assessment of fat depots (visceral adipose tissue, pericardial adipose tissue, and periaortic adipose tissue) using
multidetector computed tomography and were followed up longitudinally for a median of 5.0 years. Cox proportional
hazards regression models were used to examine the association of each fat depot (per 1 SD increment) with the
risk of incident cardiovascular disease, cancer, and all-cause mortality after adjustment for standard risk factors,
including body mass index.Results Overall, there were 90 cardiovascular events, 141 cancer events, and 71 deaths. After multivariable adjustment,
visceral adipose tissue was associated with cardiovascular disease (hazard ratio: 1.44; 95% conﬁdence interval:
1.08 to 1.92; p ¼ 0.01) and cancer (hazard ratio: 1.43; 95% conﬁdence interval: 1.12 to 1.84; p ¼ 0.005). Addition
of visceral adipose tissue to a multivariable model that included body mass index modestly improved cardiovascular
risk prediction (net reclassiﬁcation improvement of 16.3%). None of the fat depots were associated with all-cause
mortality.Conclusions Visceral adiposity is associated with incident cardiovascular disease and cancer after adjustment for clinical risk
factors and generalized adiposity. These ﬁndings support the growing appreciation of a pathogenic role of ectopic
fat. (J Am Coll Cardiol 2013;62:921–5) ª 2013 by the American College of Cardiology FoundationVisceral adipose tissue (VAT) has been cross-sectionally
associated with cardiovascular disease (CVD) and cancer
(1,2) and is correlated with smaller ectopic fat depots,
including pericardial and periaortic fat, which surround the
cardiovascular system and may exert local toxic effects (3).
These smaller ectopic fat depots have been associated withr Medicine, Brigham and Women’s Hospital,
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012; revised manuscript received May 28, 2013,cardiovascular risk factors and events (4,5). Despite the
interest in ectopic fat, few studies have examined prospective
outcomes (6–9). In addition, little is known about CVD risk
prediction, which can be useful to assess the predictive utility
of new measures for incident disease. The purpose of the
current study was to examine the association of directly
imaged fat measurements with incident CVD, cancer, and
all-cause mortality.Methods
Study sample. Participants were drawn from the Fra-
mingham Heart Study Offspring and Third Generation
cohorts who underwent multidetector computed tomography
(MDCT) from 2002 to 2005 (10). Of the 3,529 participants
in the MDCT substudy, 3,394 had at least one evaluable fat
depot measurement, 3,114 were free of CVD, 3,270 were free
of cancer, and 3,086 had complete covariates.
The study protocol was approved by the institutional
review boards of Boston University Medical Center and
Figure 1 Multidetector Co
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922Massachusetts General Hospital.
Participants provided written in-
formed consent.
MDCT scan protocol and adipose
tissue measurements. Participants
underwent thoracic and abdominal
MDCT using an 8-slice scanner.
Details of MDCT protocols and
measurement of fat volumes have
been previously described (4,5,10).
The estimated dose-length product
as a measure of radiation exposure
was approximately 300 mGy/cm.
Figure 1 shows representative im-
ages of our 3 fat depots.
Outcome assessment. CVD events(myocardial infarction, angina pectoris, coronary insufﬁ-
ciency, cerebrovascular accident, transient ischemic attack,
intermittent claudication, congestive heart failure, and
CVD death) and cause of death were adjudicated by 3
investigators. Cancer events were validated using medical
records (pathology reports). Nonmelanoma skin cancers
were not included.
Risk factor assessment. Risk factors were measured at the
seventh offspring (1998 to 2001) and ﬁrst third-generation
(2002 to 2005) examinations. Descriptions of the
measurement of risk factors were previously reported (10).
Statistical analysis. Cox proportional hazards regression
models were used to relate each adiposity measure to: 1)
incident CVD: 2) incident cancer; and 3) all-cause mortality.
Subjects with prevalent disease were excluded from the
respective analyses. VAT, pericardial fat, and periaortic fat
were the primary exposures. Multivariable models included
age, sex, systolic blood pressure, hypertension treatment,
diabetes, smoking status, total and high-density lipoprotein
cholesterol, and body mass index (BMI). Hazard ratiosmputed Tomography Images Demonstratin
landmarks, and pixels of adipose tissue within a give
et al. (4). SAT ¼ subcutaneous adipose tissue; VAT(HRs) are presented per 1 SD increment of each adiposity
measure.
For ectopic fat depots associated with CVD in multi-
variable models, we used several indices to determine the
incremental predictive utility of the given fat depot for
identifying individuals at risk for CVD. We assessed
increment in the c-statistic to assess discrimination, net
reclassiﬁcation index (NRI) to assess risk reclassiﬁcation,
relative integrated discrimination index to assess risk
reclassiﬁcation, and calibration indices based on the
Hosmer-Lemeshow goodness-of-ﬁt test. For the NRI, we
used the following categories based on the risk of CVD
during our median follow-up of 5.0 years: 0 to 3.5%, 3.6 to
8.0%, 8.1 to 11.5%, and >11.5%. To compare risk predic-
tion between different adiposity measures, we calculated the
NRI for BMI, waist circumference, and VAT in multivar-
iable models that did not include BMI (to allow for
comparison). In secondary analyses, we examined the asso-
ciation of pericardial fat with myocardial infarction. We
assessed effect modiﬁcation by age (continuous) and sex.
All analyses were conducted with SAS version 9.2 (Cary,
North Carolina). To account for 3 exposures, we used
a p value of <0.017 (0.05/3) for our primary analyses.
Results
The mean age of the subjects was 50.2 years, and 49% were
women. The mean BMI was in the overweight range
(Table 1).
Cardiovascular disease. There were 90 CVD events, and
the median follow-up time was 5.0 years (interquartile range:
3.9 to 6.0; maximum follow-up of 7.4 years). In multivariable-
adjusted models, VAT was associated with incident CVD
(HR: 1.44; p¼ 0.014) (Table 2) and remained associated with
CVD when models were adjusted for waist circumference
(HR: 1.47; 95% conﬁdence interval [CI]: 1.09 to 1.98;g SAT, VAT, Periaortic Fat, and Pericardial Fat
n fat depot are identiﬁed by their characteristic Hounsﬁeld units. The middle panel
¼ visceral adipose tissue.
Table 1
Baseline Characteristics of the Overall Sample
(N ¼ 3,086)
Age (yrs) 50.2 (10.0)
Total cholesterol (mg/dl) 199 (35)
High-density lipoprotein cholesterol (mg/dl) 54 (17)
Systolic blood pressure (mm Hg) 122 (16)
Hypertension (%) 26.7
Hypertension treatment (%) 16.4
Smoking status (%)
Current 12.5
Former 38.2
Never 49.3
Diabetes, % 5.4
Adiposity measures
Body mass index (kg/m2) 27.7 (5.2)
Waist circumference (cm) 96.7 (14.2)
SAT (cm3) 2,874 (1,393)
VAT (cm3) 1,760 (999)
Pericardial fat (cm3) 111 (43)
Periaortic fat (cm3) 13.2 (7.7)
Values are n (%) or mean  SD.
SAT ¼ subcutaneous adipose tissue; VAT ¼ visceral adipose tissue.
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923p ¼ 0.012). In contrast, there was no association of subcuta-
neous adipose tissue (SAT) and CVD. Figure 2 presents the
Kaplan-Meier curves for CVD and cancer by tertile of VAT.
CVD risk prediction. The c-statistic of the multivariable
model was similar before (0.775) and after (0.781) the addi-
tion of VAT (p value for difference between models ¼ 0.18),
suggesting similar discrimination of the models. However,
the c-statistic has been recognized as relatively insensitive at
comparing models after the inclusion of standard risk factors
(11). Thus, we calculated the NRI and observed modestTable 2
The Association of Ectopic Fat Depots Wi
All-Cause Mortality (n ¼ 71)
Age- and Sex-Adjusted Model,
HR (95% CI)
CVD
VAT 1.48 (1.21–1.81)
Periaortic fat 1.41 (1.16–1.71)
Pericardial fat 1.24 (1.05–1.46)
SAT 1.23 (0.99–1.53)
Cancer
VAT 1.22 (1.03–1.46)
Periaortic fat 1.21 (1.02–1.44)
Pericardial fat 1.20 (1.05–1.39)
SAT 0.98 (0.82–1.18)
All-cause mortality
VAT 1.26 (1.01–1.57)
Periaortic fat 1.28 (1.05–1.55)
Pericardial fat 1.31 (1.10–1.55)
SAT 1.07 (0.81–1.40)
A p value of <0.017 was considered statistically signiﬁcant. *Adjusted for a
lipoprotein cholesterol, current smoking, hypertension treatment, and body m
was 0.082 (95% CI: 0.003 to 0.176) after the addition of VAT to the multiva
12.9 (p ¼ 0.2), suggesting good calibration.
CI ¼ conﬁdence interval; CVD ¼ cardiovascular disease; HR ¼ hazard ratioimprovement in risk prediction in models containing VAT
(NRI of 16.3%; 95% CI: 2.8% to 39.3%), with 14.2%
reﬂecting appropriate upward reclassiﬁcation and 2.1%
reﬂecting appropriate downward reclassiﬁcation of subjects.
When the NRI of BMI, waist circumference, and VAT were
compared (in multivariable models that did not contain BMI
to allow comparison), the NRI for VAT (10.1%; 95%
CI: 2.5% to 17.6%) was higher than that of BMI (2.7%;
95% CI: 9.0% to 3.5%) or waist circumference (0.3%; 95%
CI: 5.7% to 6.3%).
Cancer events. VAT, but not SAT, was associated with
incident cancer in multivariable models (HR: 1.43; 95% CI:
1.12 to 1.84; p ¼ 0.005) (Table 2). Findings were similar
after additional adjustment for waist circumference instead
of BMI (HR: 1.41; 95% CI: 1.09 to 1.83; p ¼ 0.008).
All-cause mortality. There were 71 all-cause deaths. We
observed no association between ectopic fat and all-cause
mortality in multivariable models (HR for VAT: 1.05;
95% CI: 0.77 to 1.43; p ¼ 0.7) (Table 2).
Secondary analyses. We observed no association between
pericardial fat and myocardial infarction (47 events; HR:
0.97; 95% CI: 0.73 to 1.28; p ¼ 0.8). There was no effect
modiﬁcation by age or sex. Given the reported difference in
fat distribution by sex (12), sex-stratiﬁed analyses were
performed (Table 3). Despite the nonsigniﬁcant p values for
sex interaction, the HRs for CVD and cancer tended to be
higher for men.Discussion
Visceral adiposity was associated with incident CVD and
cancer above and beyond BMI or waist circumference. In
contrast to prior studies of BMI and waist circumference,th Incident CVD (n ¼ 90), Cancer (n ¼ 141), and
p Value
Multivariable* Model,
HR (95% CI) p Value
<0.001 1.44 (1.08–1.92)y 0.014
<0.001 1.31 (1.03–1.67) 0.03
0.01 1.11 (0.91–1.35) 0.3
0.06 0.99 (0.66–1.49) 1.0
0.03 1.43 (1.12–1.84) 0.005
0.03 1.22 (0.99–1.50) 0.06
0.02 1.17 (0.98–1.38) 0.08
0.9 0.90 (0.65–1.26) 0.5
0.04 1.05 (0.77–1.43) 0.7
0.01 1.08 (0.85–1.38) 0.5
0.002 1.17 (0.95–1.44) 0.1
0.7 0.72 (0.45–1.15) 0.2
ge, sex, systolic blood pressure, diabetes, total cholesterol, high-density
ass index. yFor the CVD outcome, the integrated discrimination index
riable model. The chi-square statistic (p value) for model calibration was
. Abbreviations as in Table 1.
Table 3
Association of Multiple Fat Depots With Incident CVD (40 E
(68 Events in Women, 73 Events in Men) Stratiﬁed by Sex
Adiposity Measure
Women
(n ¼ 1,519)
Age-Adjusted Model Multivariable Model*
Incident CVD
VAT 1.20 (0.90–1.59) 1.04 (0.65–1.65)
Periaortic fat 1.19 (0.91–1.56) 1.08 (0.75–1.55)
Pericardial fat 1.13 (0.85–1.49) 0.97 (0.69–1.36)
SAT 1.24 (0.90–1.71) 1.33 (0.72–2.45)
Incident cancer
VAT 1.19 (0.94–1.49) 1.27 (0.88–1.82)
Periaortic fat 1.28 (1.02–1.62) 1.31 (0.97–1.77)
Pericardial fat 1.06 (0.83–1.35) 0.96 (0.72–1.29)
SAT 1.00 (0.78–1.28) 0.80 (0.49–1.30)
All-cause death
VAT 1.12 (0.77–1.62) 1.18 (0.66–2.14)
Periaortic fat 1.06 (0.72–1.55) 1.05 (0.64–1.71)
Pericardial fat 1.11 (0.77–1.60) 1.09 (0.73–1.64)
SAT 0.84 (0.54–1.32) 0.73 (0.32–1.63)
Values are HR (95% CI). *Adjusted for age, systolic blood pressure, diabetes, total cholesterol, high-de
interaction is age adjusted.
Abbreviations as in Tables 1 and 2.
Figure 2
Kaplan-Meier Curve of Time to
Cardiovascular Disease and Cancer by Tertile of VAT
Vertical axes show the percentage of subjects developing (A) cardiovascular
disease and (B) cancer during follow-up; horizontal axes reﬂect years of follow-up.
Tertile cutpoints for VAT are 1,242.2 and 2,168.4 cm3. Abbreviation as in Figure 1.
Britton et al. JACC Vol. 62, No. 10, 2013
Body Fat Distribution/Incident Health Outcomes September 3, 2013:921–5
924visceral adiposity modestly improved CVD risk prediction.
These results support the hypothesis that visceral fat may
partially underlie the association of clinical adiposity
measures with CVD and cancer.
Cross-sectional studies have demonstrated associations
between ectopic fat and CVD and cancer (1,2), but few
prospective studies are available (6–9,13). Our ﬁndings
expand the literature with the use of a prospective cohort
that avoided selection or sampling bias and a sample size of
more than 3,000 individuals with a wide age range. Unlike
prior studies, we assessed risk prediction. Our ﬁnding of
a modest improvement in risk prediction with VAT stands
in contrast to the lack of improvement with waist circum-
ference (14). One potential explanation is that waist
circumference is a surrogate marker of visceral adiposity and
reﬂects both SAT and VAT.
Numerous experimental studies support a potential link
between VAT and biological pathways important in the
pathogenesis of multiple disease outcomes. Adipokines,
biologically active molecules secreted from adipose tissue,
are key components of these pathways and include inﬂa-
mmatory cytokines, angiogenic factors, lipid metabolites,
and extracellular matrix components (15). Adipokine
secretion appears to differ between speciﬁc fat depots (16),
with VAT demonstrating greater expression of proin-
ﬂammatory and proangiogenic genes compared with SAT
(17). Furthermore, arterioles within VAT compared with
SAT were more likely to exhibit endothelial dysfunction
(17), suggesting a potential toxic effect of VAT on the
vasculature.
Given the worldwide obesity epidemic, identiﬁcation
of high-risk individuals is important because it allows tar-
geting of preventive and therapeutic measures. Furthermore,vents in Women, 50 Events in Men) and Incident Cancer
Men
(n ¼ 1,567)
p Value
for InteractionyAge-Adjusted Model Multivariable Model
1.64 (1.27–2.11) 1.66 (1.16–2.39) 0.1
1.47 (1.16–1.85) 1.37 (1.02–1.84) 0.5
1.28 (1.05–1.55) 1.16 (0.91–1.47) 0.4
1.22 (0.93–1.61) 0.79 (0.47–1.33) 1.0
1.20 (0.96–1.49) 1.43 (1.06–1.94) 0.4
1.11 (0.90–1.38) 1.13 (0.86–1.49) 1.0
1.25 (1.05–1.48) 1.24 (1.02–1.51) 0.06
0.98 (0.76–1.27) 0.99 (0.64–1.54) 0.9
1.27 (0.99–1.62) 0.92 (0.65–1.28) 0.3
1.28 (1.04–1.58) 0.95 (0.72–1.24) 0.2
1.36 (1.12–1.65) 1.16 (0.91–1.46) 0.2
1.26 (0.91–1.74) 0.74 (0.41–1.33) 0.2
nsity lipoprotein cholesterol, current smoking, hypertension treatment, and body mass index. yp
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925markers of risk may provide insight into the biology linking
body fat distribution and outcomes. Our ﬁnding that the
association of VAT with events was not completely
explained by standard risk factors is consistent with evidence
suggesting that the link between VAT and obesity-related
complications may involve novel biological pathways.
Study limitations. Our sample was predominantly white. In
addition, our study was observational, preventing inferences of
causality and treatment recommendations. Data on weight
change were not available for our participants during the
follow-up period. Finally, these ﬁndings do not imply that
quantiﬁcation of fat by MDCT should be used clinically.
Conclusions
Visceral adiposity is associated with incident CVD and
cancer after adjustment for clinical risk factors and general-
ized or central adiposity. These ﬁndings support the growing
appreciation of a pathogenic role of ectopic fat depots.
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